Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
CH-4051
.
Show all posts
Showing posts with label
CH-4051
.
Show all posts
Monday, July 23, 2012
RA Study Misses Primary Endpoint (CH-4051)...
›
In continuation of my update on CH-4051 Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that a preliminary analysis of...
›
Home
View web version
